Exchange: NASDAQ·Updated 06:27 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 06

Estimated EPS

-$0.24

Reported EPS

-$0.14

Surprise

+42.41%

Estimated Rev

$146.67M

Reported Rev

$151.04M

Surprise

+2.97%

• Reported GAAP EPS of -$0.14 down -150.00% YoY • Reported revenue of $151.04M down -12.65% YoY • 10x Genomics is raising its full year 2026 revenue guidance and now expects revenue in the range of $610 million to $630 million, representing 2% to 5% growth over 2025.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.27
--
--
N/A
Q2 '26
-$0.24
-$0.14
42.41%
BEAT
Q1 '26
-$0.28
-$0.10
63.65%
BEAT
Q4 '25
-$0.20
-$0.13
35.89%
BEAT
Q3 '25
-$0.29
-$0.22
23.71%
BEAT

Advertisement|Remove ads.